http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-790611-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C403-14
filingDate 1955-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1958-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-790611-A
titleOfInvention A process for the manufacture of unsaturated aldehydes
abstract A process for the manufacture of unsaturated aldehydes of the general formula: <FORM:0790611/IV (b)/1> wherein X stands for the group -CH = O or -CH = CH-CH = O or <FORM:0790611/IV (b)/2> and acetals thereof comprise brominating an aldehyde of the general formula: <FORM:0790611/IV (b)/3> in which X has the significance already given, or an acetal thereof by a Wohl-Ziegler reaction and heating the product with a tertiary amine and, if desired, hydrolysing or partially hydrolysing any acetal group present in said product. Preferably N-bromo-succimide or N-bromo-acetamide in an inert organic solvent, carbon tetrachloride, chloroform, benzene or methylene chloride, is used for the bromination, which is accelerated by the addition of dibenzoyl peroxide or irradiation. When N-bromosuccinimide is used sodium bicarbonate and calcium hydroxide are suitably added to the brominated mixture. Bromo-aldehydes of the general formula: <FORM:0790611/IV (b)/4> wherein X has the significance already given, and acetals thereof are the products of the first stage of the process. Tertiary amines employed in the second step include quinoline, pyridine, dimethyl aniline or collidine. The product may be treated with ice-cold dilute acid and extracted with organic solvent, e.g. petroleum ether. Where the product is an acetal and it is desired to minimize hydrolysis the organic solvent may be added before the treatment with dilute acid. Where it is desired to hydrolyse the acetal group the product is treated with an acid, e.g. acetic acid preferably with the addition of sodium acetate. The retrodehydro-C14- and C16-aldehydes and their acetals may be converted to the retrodehydro-C16- and C19-aldehydes by the processes of Specifications 790,613 and 790,612. In examples, retrodehydro-C14-aldehyde is obtained by treating 4-[21,61,61-trimethyl-cyclohexen - (1) - yl] - 2 - methyl - buten - (2) - al - (1) in the presence of methylene chloride, sodium bicarbonate and calcium oxide with N-bromo-succinimide, heating the product with quinoline and extracting with petroleum ether (1); a mixture of retrodehydro-C16-aldehyde isomers is similarly obtained from 6-[21,61,61-trimethyl-cyclohexen - (11) - yl] - 4 - methyl - hexadien-(2,4) - ol - 1 (2), retrodehydro - C19 - aldehyde is similarly obtained from 8-[21,61,61-trimethyl cyclohexen - (11) - yl] - 2,6 - dimethyl - octatrien-(2,4,6) - al - 1 (3); retrodehydro - C14 - aldehyde is also obtained by converting 4-(21,61,61-tri - methyl - cyclohexen - (11) - yl] - 2 - methyl-1,1 - diethoxy - butene - (2) to retrodehydro-C14-aldehyde-diethyl acetal by a similar process and heating the product with sodium acetate, acetic acid and water to effect hydrolysis (4). 4 - [21,61,61 - Trimethyl - cyclohexen - (1) - yl]-2 - methyl - buten - (2) - al - (1) employed as starting material is obtained by reacting b -ionone and chloracetic acid in a glycide ester synthesis and treating the product with alkali. 6 - [21,61,61 - trimethyl - cyclohexen - (11) - yl]-4 - methyl - hexadien - (2,4) - al - 1 is obtained from 4 - [21,61,61 - trimethyl - cyclohexen - (11)-yl - 2 - methyl - buten - (2) - ol - (1). 8 - [21,6,61 - trimethyl - cyclohexen - (11) - yl]-2,6 - dimethyl - octatrien - (2,4,6) - al - (1) is ob-tained by treating the latter with orthoformic acid ethyl ester in the presence of p-toluene-sulphonic acid, condensing the resulting diethyl acetal with ethyl propenyl ether in the presence of zinc chloride and heating the 8-[21,61,61-tri methyl - cyclohexen - (11) - yl] - 2,6 - dimethyl-1,1,3 - triethoxy - octadien - (4,6) with acetic acid and sodium acetate to hydrolyse the acetal group and split off the elements of ethyl alcohol. The above aldehydes may be converted to acetals for use as starting materials, e.g. by treatment with orthoformic ethyl ester in the presence of p-toluene-sulphonic acid. Specifications 753,552 and 753,559 also are referred to.
priorityDate 1954-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7765
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424983022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449957047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408599808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420266533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447730362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413305291

Total number of triples: 62.